DK1244662T3 - Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter - Google Patents

Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter

Info

Publication number
DK1244662T3
DK1244662T3 DK00987935T DK00987935T DK1244662T3 DK 1244662 T3 DK1244662 T3 DK 1244662T3 DK 00987935 T DK00987935 T DK 00987935T DK 00987935 T DK00987935 T DK 00987935T DK 1244662 T3 DK1244662 T3 DK 1244662T3
Authority
DK
Denmark
Prior art keywords
pyridazinoquinoline
derivatives
treating pain
pain
treating
Prior art date
Application number
DK00987935T
Other languages
English (en)
Inventor
Thomas Michael Bare
Dean Gordon Brown
Megan Murphy
Rebecca Ann Urbanek
Wenhua Xiao
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1244662T3 publication Critical patent/DK1244662T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00987935T 1999-12-23 2000-12-19 Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter DK1244662T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23678300P 2000-09-29 2000-09-29
PCT/SE2000/002611 WO2001047927A1 (en) 1999-12-23 2000-12-19 Compound and method for the treatment of pain

Publications (1)

Publication Number Publication Date
DK1244662T3 true DK1244662T3 (da) 2005-07-11

Family

ID=26867555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00987935T DK1244662T3 (da) 1999-12-23 2000-12-19 Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter

Country Status (29)

Country Link
EP (1) EP1244662B1 (da)
JP (1) JP2003519149A (da)
KR (1) KR20020062369A (da)
CN (1) CN1188413C (da)
AR (1) AR027037A1 (da)
AT (1) ATE294177T1 (da)
AU (1) AU779703B2 (da)
BG (1) BG106831A (da)
BR (1) BR0016654A (da)
CA (1) CA2394888A1 (da)
CO (1) CO5271689A1 (da)
CZ (1) CZ296877B6 (da)
DE (1) DE60019807T2 (da)
DK (1) DK1244662T3 (da)
EE (1) EE200200350A (da)
ES (1) ES2239632T3 (da)
HK (1) HK1048811B (da)
HU (1) HUP0300313A3 (da)
IL (1) IL150208A0 (da)
IS (1) IS6427A (da)
MX (1) MXPA02006155A (da)
MY (1) MY133596A (da)
NO (1) NO20022984L (da)
NZ (1) NZ519390A (da)
PL (1) PL356664A1 (da)
PT (1) PT1244662E (da)
RU (1) RU2234507C2 (da)
SK (1) SK8792002A3 (da)
WO (1) WO2001047927A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process
EP2074992B1 (en) * 2005-04-08 2015-05-20 Abbott Laboratories Oral pharmaceutical formulations comprising salts of fenofibric acid
JP5790533B2 (ja) * 2012-02-14 2015-10-07 住友化学株式会社 フェニルヒドラジン−β−カルボキシレート化合物の精製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111266A (en) * 1993-10-22 2002-03-10 Zeneca Ltd 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
ATE294177T1 (de) 2005-05-15
EP1244662B1 (en) 2005-04-27
NO20022984L (no) 2002-08-20
HUP0300313A2 (hu) 2003-06-28
PT1244662E (pt) 2005-07-29
CO5271689A1 (es) 2003-04-30
RU2234507C2 (ru) 2004-08-20
MY133596A (en) 2007-11-30
CA2394888A1 (en) 2001-07-05
CZ296877B6 (cs) 2006-07-12
KR20020062369A (ko) 2002-07-25
PL356664A1 (en) 2004-06-28
CN1411459A (zh) 2003-04-16
ES2239632T3 (es) 2005-10-01
BG106831A (en) 2003-03-31
IS6427A (is) 2002-06-19
CZ20022177A3 (cs) 2002-11-13
AU779703B2 (en) 2005-02-10
HK1048811A1 (en) 2003-04-17
DE60019807D1 (de) 2005-06-02
EE200200350A (et) 2003-10-15
JP2003519149A (ja) 2003-06-17
AR027037A1 (es) 2003-03-12
HUP0300313A3 (en) 2007-05-02
EP1244662A1 (en) 2002-10-02
SK8792002A3 (en) 2003-05-02
WO2001047927A1 (en) 2001-07-05
MXPA02006155A (es) 2002-12-05
HK1048811B (zh) 2005-09-30
CN1188413C (zh) 2005-02-09
IL150208A0 (en) 2002-12-01
NZ519390A (en) 2003-07-25
AU2420301A (en) 2001-07-09
DE60019807T2 (de) 2006-01-19
NO20022984D0 (no) 2002-06-20
BR0016654A (pt) 2002-09-03

Similar Documents

Publication Publication Date Title
NO20014504D0 (no) Anordning og fremgangsmåte for rehabilitering av tinnitus
DK1231887T3 (da) Fremgangsmåde og sammensætning til behandling af ar
DK1041879T3 (da) Desinfektionsmiddel og fremstillingsmetode
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
NO20002908L (no) Fremgangsmåte og anordning for borehullsundersökelser
DK2282002T3 (da) Fremgangsmåde og anordning til stimulering af flere formationsintervaller
NO20005017L (no) Metoder og viskøse sammensetninger for behandling av brønner
NO20006604D0 (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
DK0861588T3 (da) Fremgangsmåde til sterilisering af jord og tilhørende udstyr
NO20002584D0 (no) Brønnreferanseapparat og fremgangsmÕte
NO20012289D0 (no) Anordning og fremgangsmåte for innretting
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
AR027832A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
DE60016423D1 (de) Ätzmethode und plasmabehandlungsmethode
DK1244662T3 (da) Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20012667D0 (no) Fremgangsmåte for aktivering av vann og anvendelse av aktivert vann av denne type
DK1246799T3 (da) Substituerede pyrrol-Mannich-baser til bekæmpelse af smerter og allergiske reaktioner
NO20022990L (no) Fremgangsmåte og sammensetning for behandling av smerte
NO992561D0 (no) Oppslemmingsbehandlingssystem og oppslemmingsbehandlingsmetode
DK1307761T3 (da) Fremgangsmåde til retningsbestemmelse og bestemmelsesapparat
DK1389100T3 (da) Hidtil ukendte fremgangsmåder til behandling og forebyggelse af smerte under anvendelse af stressaktiverede proteinkinaseinhibitorer
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
NO20022482D0 (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav